BMRA
Price
$1.71
Change
-$0.00 (-0.00%)
Updated
Oct 22 closing price
Capitalization
7.85M
Intraday BUY SELL Signals
LFWD
Price
$5.91
Change
+$0.42 (+7.65%)
Updated
Oct 22 closing price
Capitalization
16.74M
22 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BMRA vs LFWD

BMRA vs LFWD Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BMRA vs. LFWD commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRA is a StrongBuy and LFWD is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for BMRA with price predictions
Oct 22, 2026

BMRA's Stochastic Oscillator is staying in oversold zone for 17 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BMRA as a result. In 76 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.

The Moving Average Convergence Divergence Histogram (MACD) for BMRA turned negative on September 25, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In 37 of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

BMRA moved below its 50-day moving average on October 07, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for BMRA crossed bearishly below the 50-day moving average on October 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMRA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.

BMRA broke above its upper Bollinger Band on September 18, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for BMRA entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 38 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.366) is normal, around the industry mean (2.874). P/E Ratio (-1.062) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (1.578) is also within normal values, averaging (40.124).

The Tickeron PE Growth Rating for this company is 49 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. BMRA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMRA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

A.I.Advisor
a Summary for LFWD with price predictions
Oct 22, 2026

LFWD's RSI Indicator ascending out of oversold territory

The RSI Indicator for LFWD moved out of oversold territory on October 22, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 37 similar instances when the indicator left oversold territory. In 31 of the 37 cases the stock moved higher. This puts the odds of a move higher at 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

LFWD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 19, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on LFWD as a result. In 77 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.

The 50-day moving average for LFWD moved below the 200-day moving average on October 14, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LFWD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for LFWD entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 19 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 45 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.370) is normal, around the industry mean (2.874). P/E Ratio (-0.403) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.574) is also within normal values, averaging (40.124).

The Tickeron Price Growth Rating for this company is 81 (best 1 - 100 worst), indicating slightly worse than average price growth. LFWD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LFWD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

FUNDAMENTALS RATINGS
BMRA vs LFWD: Fundamental Ratings
BMRA
LFWD
OUTLOOK RATING
1..100
5187
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
45
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
6581
P/E GROWTH RATING
1..100
4919
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BMRA's Valuation (38) in the Medical Specialties industry is in the same range as LFWD (45). This means that BMRA’s stock grew similarly to LFWD’s over the last 12 months.

BMRA's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as LFWD (100). This means that BMRA’s stock grew similarly to LFWD’s over the last 12 months.

BMRA's SMR Rating (98) in the Medical Specialties industry is in the same range as LFWD (100). This means that BMRA’s stock grew similarly to LFWD’s over the last 12 months.

BMRA's Price Growth Rating (65) in the Medical Specialties industry is in the same range as LFWD (81). This means that BMRA’s stock grew similarly to LFWD’s over the last 12 months.

LFWD's P/E Growth Rating (19) in the Medical Specialties industry is in the same range as BMRA (49). This means that LFWD’s stock grew similarly to BMRA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMRALFWD
RSI
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 1 day ago
78%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (BMRA: $1.71 vs. LFWD: $5.49)
Brand notoriety: BMRA and LFWD are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BMRA: 9% vs. LFWD: 61%
Market capitalization -- BMRA: $7.85M vs. LFWD: $16.74M
BMRA [@Medical/Nursing Services] is valued at $7.85M. LFWD’s [@Medical/Nursing Services] market capitalization is $16.74M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $173.92B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMRA’s FA Score shows that 0 FA rating(s) are green while LFWD’s FA Score has 1 green FA rating(s).

  • BMRA’s FA Score: 0 green, 5 red.
  • LFWD’s FA Score: 1 green, 4 red.
According to our system of comparison, BMRA is a better buy in the long-term than LFWD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMRA’s TA Score shows that 3 TA indicator(s) are bullish while LFWD’s TA Score has 3 bullish TA indicator(s).

  • BMRA’s TA Score: 3 bullish, 7 bearish.
  • LFWD’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, LFWD is a better buy in the short-term than BMRA.

Price Growth

BMRA (@Medical/Nursing Services) experienced а -7.57% price change this week, while LFWD (@Medical/Nursing Services) price change was -10.15% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.

Reported Earning Dates

LFWD is expected to report earnings on Nov 13, 2026.

Industries' Descriptions

@Medical/Nursing Services (-1.62% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
BMRA
Daily Signal:
Gain/Loss:
LFWD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

BMRA and

Correlation & Price change

A.I.dvisor tells us that BMRA and TRIB have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BMRA and TRIB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRA
1D Price
Change %
BMRA100%
N/A
TRIB - BMRA
33%
Poorly correlated
-2.79%
NVCR - BMRA
28%
Poorly correlated
-3.14%
LFWD - BMRA
26%
Poorly correlated
+7.65%
NNOX - BMRA
26%
Poorly correlated
-0.36%
VNRX - BMRA
25%
Poorly correlated
+1.62%
More

LFWD and

Correlation & Price change

A.I.dvisor tells us that LFWD and MBOT have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LFWD and MBOT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFWD
1D Price
Change %
LFWD100%
+7.65%
MBOT - LFWD
27%
Poorly correlated
+0.19%
ALGN - LFWD
27%
Poorly correlated
+2.74%
UFPT - LFWD
25%
Poorly correlated
+2.49%
LUCD - LFWD
25%
Poorly correlated
-1.71%
QSI - LFWD
25%
Poorly correlated
-6.50%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRCB9.650.99
+11.43%
Black Rock Coffee Bar Inc
GFF97.002.37
+2.50%
Griffon Corp
ODFL189.890.99
+0.52%
Old Dominion Freight Line
KELYB26.060.06
+0.23%
Kelly Services
TCRX0.22-0.01
-3.48%
TScan Therapeutics